Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services.The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict that patients with MCI will develop Alzheimer’s disease.
Its biomarkers are based on the cell cycle hypothesis of Alzheimer’s disease discovered.Cytox offers Cytox variatech SNP research assay that is a biomarker research assay to reduce screening failure in clinical trials and helps in novel drug discovery.
The company also provides biomarker services to pharmaceutical industry clients to conduct clinical trials with drugs for the treatment of Alzheimer’s disease and mild cognitive impairment.It partners with pharmaceutical industry and academic researchers to develop blood-based assays.
Cytox is headquartered in Oxford, the UK.
Cytox Ltd - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
3D Printing Medical Devices Market Research Report by Component (Ceramics, Equipment, Materials, Paper, and Services & Software), by Technology (Droplet Deposition Or Extrusion-Based Technologies, Electron Beam Melting, Laser Beam Melting, Photopolymerization, and Three-Dimensional Printing), by Type - Global Forecast to 2025 - Cumulative...
Medical Device Electrodes Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Medical Device Electrodes market including the COVID-19 pandemic implications...
Medical Device Contract Manufacturing Market Research Report by Services (Device Development and Manufacturing Services, Final Goods Assembly Services, and Quality Management Services), by Class of Device (Class I Medical Devices, Class II Medical Devices, and Class III Medical Devices), by Device Type - Global Forecast to 2025 - Cumulative...
The North Americamedical devices market was valued at US$ 197,215.1million in 2019 and is projected to reach US$ 318,973.1million by 2027; it is expected to grow at a CAGR of 6.4% during 2020–2027. The growth of the medical device market is mainly attributed to the growing medical device industry, and rising chronic disease prevalence....
Huntington Disease Global Clinical Trials Review, H2, 2020 Summary Clinical trial report, “Huntington Disease Global Clinical Trials Review, H2, 2020" provides an overview of Huntington Disease Clinical trials scenario.This report provides top line data relating to the clinical trials on Huntington...
178 pages •
By Global Industry Analysts
• Jul 2020
Global Medical Device Connectivity Market to Reach $4 Billion by 2027 Amid the COVID-19 crisis, the global market for Medical Device Connectivity estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at aCAGR of 20% over the period 2020-2027. Solutions, one of the segments...
Insulin Like Growth Factor I - Pipeline Review, H1 2020 Summary According to the recently published report ’Insulin Like Growth Factor I – Pipeline Review, H1 2020’; Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) pipeline Target constitutes close to 9 molecules. Out...
239 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
Down Syndrome - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Down Syndrome - Pipeline Review, H2 2020, provides an overview of the Down Syndrome (Genetic Disorders) pipeline landscape. Down syndrome is a genetic disorder that causes lifelong...